Form 4: Alignment Healthcare CIO Sells Over 100,000 Shares Under Pre-Arranged Trading Plan

Alignment Healthcare's Chief Information Officer, Robert L. Scavo, sold a total of 100,863 shares of common stock in early June 2025, pursuant to a Rule 10b5-1 trading plan.

Summary

• Robert L. Scavo, Chief Information Officer of Alignment Healthcare, Inc. (ALHC), disposed of 100,863 shares of common stock.
• The sales occurred on June 10, 2025, and June 11, 2025.
• On June 10, 2025, 60,000 shares were sold at a price of $14.6008 per share.
• On June 11, 2025, 40,863 shares were sold at a weighted-average price of $15.2022 per share, with prices ranging from $15.10 to $15.51.
• These transactions were executed under a Rule 10b5-1 trading plan adopted on March 11, 2025.
• Following these sales, Mr. Scavo beneficially owns 602,090 shares of Alignment Healthcare common stock directly.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to a significant insider sale, although mitigated by the fact it was conducted under a pre-arranged 10b5-1 plan, which suggests it was not based on immediate negative news.

Positives

• The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating the transactions were scheduled in advance and not based on immediate, non-public information.

Negatives

• An insider sale, particularly by a Chief Information Officer, could be perceived by some investors as a negative signal regarding management's outlook on the company's future stock performance.
• The sale represents a significant disposition of shares by a key executive.

Risks

• Investor perception risk: Large insider sales, even under 10b5-1 plans, can sometimes lead to negative investor sentiment or speculation about the company's future prospects.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• The filing notes that the reporting person undertakes to provide full information regarding the number of shares sold at each price within the reported range upon request.

Industry Context

This specific insider transaction by a Chief Information Officer of a healthcare company does not directly reflect broader industry trends but is a routine disclosure of executive stock activity. It provides insight into individual executive portfolio management within the healthcare sector.

Comparison to Industry Standards

• This document, being a Form 4 detailing an insider stock sale, does not provide information suitable for direct comparison to industry-wide financial or operational benchmarks. Insider trading activity varies widely across companies and industries, and the presence of a 10b5-1 plan aligns with best practices for executives managing their equity holdings.

Stakeholder Impact

• Shareholders: May interpret the insider sale as a signal regarding the executive's view on future stock performance, potentially influencing their investment decisions.

Next Steps

• The document does not specify any future actions or milestones for the company, beyond the standard reporting requirements for insider transactions.

Key Dates

Recommendation

Keywords

Alignment Healthcare, ALHC, Form 4, Insider Trading, Stock Sale, Robert L. Scavo, Chief Information Officer, 10b5-1 Plan, SEC Filing, Healthcare Stock